Shoulder Biologics: Evidence, Limits & Safety
Separate established recovery care from promising ideas that have not demonstrated a dependable clinical benefit.
Start with the diagnosis and recovery fundamentals
A biologic product does not replace a diagnosis, rehabilitation, adequate nutrition, or indicated surgery. Ask whether the goal is pain relief, tendon healing, muscle preservation, or treatment of arthritis. Evidence for one goal does not establish benefit for another.
Platelet-rich plasma
PRP preparations and uses vary. Routine injections for rotator cuff tendinopathy or partial tears are not supported by the 2025 AAOS guideline. Use during a surgical repair is a separate clinical question. Read the dedicated PRP guide for the questions to ask before treatment.
Stem-cell and tissue-derived products
“Stem cell” is used in marketing for products that are not equivalent. Processing, source, regulatory status, and intended use matter. FDA warns that regenerative products have been marketed for orthopedic problems without established safety and effectiveness. Do not assume that a product described as natural, autologous, or registered is approved for treating your shoulder.
Exosomes
Exosomes are cell-derived particles studied for signaling effects. Laboratory interest is not proof that an injected product treats shoulder arthritis or repairs a tendon. FDA’s consumer alert states that there are no FDA-approved exosome products; ask about the current authorization for the specific proposed product and indication.
Peptides and postoperative recovery
Evidence from cells or animals does not establish a safe, effective postoperative regimen in people. BPC-157 and TB-500 should not be presented as proven shoulder-healing treatments. Product quality, human safety data, and regulatory status require scrutiny. A faster return to loading should never be based on taking an experimental product.
How to judge a research claim
- Was the study in people with the same condition and treatment?
- Did it measure pain, function, reoperation, or tendon healing—not only a laboratory marker?
- Was there a comparison group, and how long were patients followed?
- What harms were measured, and who funded the study?
Biologics after surgery
Do not add an injection or supplement to the postoperative plan without the treating surgeon’s knowledge. The repair, incision, medication list, and rehabilitation restrictions remain the starting point.